Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Toxoplasma gondii Recombinant antigen AMA1: Diagnostic Utility of Protein Fragments for the Detection of IgG and IgM Antibodies.

Ferra B, Holec-Gąsior L, Gatkowska J, Dziadek B, Dzitko K.

Pathogens. 2020 Jan 5;9(1). pii: E43. doi: 10.3390/pathogens9010043.

2.

The Impact of the Antigenic Composition of Chimeric Proteins on Their Immunoprotective Activity against Chronic Toxoplasmosis in Mice.

Gatkowska J, Dzitko K, Ferra BT, Holec-Gąsior L, Kawka M, Dziadek B.

Vaccines (Basel). 2019 Oct 18;7(4). pii: E154. doi: 10.3390/vaccines7040154.

3.

In vitro biosafety of pro-ecological chitosan-based hydrogels modified with natural substances.

Tyliszczak B, Drabczyk A, Kudłacik-Kramarczyk S, Rudnicka K, Gatkowska J, Sobczak-Kupiec A, Jampilek J.

J Biomed Mater Res A. 2019 Nov;107(11):2501-2511. doi: 10.1002/jbm.a.36756. Epub 2019 Jul 30.

PMID:
31298778
4.

The first study on the usefulness of recombinant tetravalent chimeric proteins containing fragments of SAG2, GRA1, ROP1 and AMA1 antigens in the detection of specific anti-Toxoplasma gondii antibodies in mouse and human sera.

Ferra BT, Holec-Gąsior L, Gatkowska J, Dziadek B, Dzitko K, Grąźlewska W, Lautenbach D.

PLoS One. 2019 Jun 6;14(6):e0217866. doi: 10.1371/journal.pone.0217866. eCollection 2019.

5.

Assessment of the antigenic and neuroprotective activity of the subunit anti-Toxoplasma vaccine in T. gondii experimentally infected mice.

Gatkowska J, Wieczorek M, Dziadek B, Dzitko K, Dziadek J, Długońska H.

Vet Parasitol. 2018 Apr 30;254:82-94. doi: 10.1016/j.vetpar.2018.02.043. Epub 2018 Mar 1.

PMID:
29657017
6.

Exosomes in the context of Toxoplasma gondii – host communication

Długońska H, Gatkowska J.

Ann Parasitol. 2016 Oct 1;62(3):169–174. doi: 10.17420/ap6203.50. Review.

7.

The role of extracellular vesicles in parasite-host interaction.

Gatkowska J, Długońska H.

Postepy Hig Med Dosw (Online). 2016 Sep 13;70(0):951-958.

PMID:
27668647
8.

Epineurium-mimicking chitosan conduits for peripheral nervous tissue engineering.

Nawrotek K, Tylman M, Rudnicka K, Gatkowska J, Wieczorek M.

Carbohydr Polym. 2016 Nov 5;152:119-128. doi: 10.1016/j.carbpol.2016.07.002. Epub 2016 Jul 2.

PMID:
27516256
9.

Assessment of degradation and biocompatibility of electrodeposited chitosan and chitosan-carbon nanotube tubular implants.

Nawrotek K, Tylman M, Decherchi P, Marqueste T, Rudnicka K, Gatkowska J, Wieczorek M.

J Biomed Mater Res A. 2016 Nov;104(11):2701-11. doi: 10.1002/jbm.a.35812. Epub 2016 Jul 5.

PMID:
27325550
10.

The pharmaceutics from the foreign empire: the molecular pharming of the prokaryotic staphylokinase in Arabidopsis thaliana plants.

Hnatuszko-Konka K, Łuchniak P, Wiktorek-Smagur A, Gerszberg A, Kowalczyk T, Gatkowska J, Kononowicz AK.

World J Microbiol Biotechnol. 2016 Jul;32(7):113. doi: 10.1007/s11274-016-2070-z. Epub 2016 Jun 4.

11.

Tubular electrodeposition of chitosan-carbon nanotube implants enriched with calcium ions.

Nawrotek K, Tylman M, Rudnicka K, Gatkowska J, Balcerzak J.

J Mech Behav Biomed Mater. 2016 Jul;60:256-266. doi: 10.1016/j.jmbbm.2016.02.012. Epub 2016 Feb 11.

PMID:
26913639
12.

Towards vaccine against toxoplasmosis: evaluation of the immunogenic and protective activity of recombinant ROP5 and ROP18 Toxoplasma gondii proteins.

Grzybowski MM, Dziadek B, Gatkowska JM, Dzitko K, Długońska H.

Parasitol Res. 2015 Dec;114(12):4553-63. doi: 10.1007/s00436-015-4701-y. Epub 2015 Sep 4.

PMID:
26337271
13.

Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells.

Dzitko K, Grzybowski MM, Pawełczyk J, Dziadek B, Gatkowska J, Stączek P, Długońska H.

Parasit Vectors. 2015 Aug 15;8:422. doi: 10.1186/s13071-015-1019-7.

14.

Human toxoplasmosis: a comparative evaluation of the diagnostic potential of recombinant Toxoplasma gondii ROP5 and ROP18 antigens.

Grzybowski MM, Gatkowska JM, Dziadek B, Dzitko K, Długońska H.

J Med Microbiol. 2015 Oct;64(10):1201-1207. doi: 10.1099/jmm.0.000148. Epub 2015 Aug 3.

PMID:
26242602
15.

Recombinant MAG1 Protein of Toxoplasma gondii as a Diagnostic Antigen.

Gatkowska JM, Dziadek B, Dziadek J, Dzitko K, Długońska H.

Pol J Microbiol. 2015;64(1):55-9.

16.

Toxoplasma gondii: cloning, expression and immunoreactivity of recombinant ROP5 and ROP18 antigens.

Grzybowski MM, Dziadek B, Dziadek J, Gatkowska J, Dzitko K, Długońska H.

Exp Parasitol. 2015 Mar;150:1-6. doi: 10.1016/j.exppara.2015.01.006. Epub 2015 Jan 12.

PMID:
25592730
17.

Veterinary vaccines against toxoplasmosis.

Hiszczyńska-Sawicka E, Gatkowska JM, Grzybowski MM, Długońska H.

Parasitology. 2014 Sep;141(11):1365-78. doi: 10.1017/S0031182014000481. Epub 2014 May 7. Review.

PMID:
24805159
18.

Sex-dependent neurotransmitter level changes in brains of Toxoplasma gondii infected mice.

Gatkowska J, Wieczorek M, Dziadek B, Dzitko K, Dlugonska H.

Exp Parasitol. 2013 Jan;133(1):1-7. doi: 10.1016/j.exppara.2012.10.005. Epub 2012 Oct 23.

PMID:
23098668
19.

Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.

Dziadek B, Gatkowska J, Grzybowski M, Dziadek J, Dzitko K, Dlugonska H.

Exp Parasitol. 2012 May;131(1):133-8. doi: 10.1016/j.exppara.2012.02.026. Epub 2012 Mar 14.

PMID:
22445587
20.

Behavioral changes in mice caused by Toxoplasma gondii invasion of brain.

Gatkowska J, Wieczorek M, Dziadek B, Dzitko K, Dlugonska H.

Parasitol Res. 2012 Jul;111(1):53-8. doi: 10.1007/s00436-011-2800-y. Epub 2012 Jan 6.

Supplemental Content

Loading ...
Support Center